C-RAD has secured an order for three Catalyst HD™ systems and one Sentinel 4DCT™ system from Ryhov County Hospital in Jönköping, Sweden. The order has a total value of 5.2 MSEK.
The Catalyst HD™ will be delivered with the complete software configuration containing modules for Respiratory Gating, Patient Setup and Positioning, and Motion Monitoring, as well as interfaces to the CT and the Varian TrueBeam® linear accelerator. The customer also selected C-RAD’s unique audio-visual couching functionality, which supports an interactive gating mode. Delivery and installation of the order is scheduled for August, 2016.
The Catalyst HD™ and Sentinel™ systems enable the high-end treatment techniques within radiation therapy that are increasingly common. With this dual solution C-RAD supports the whole 4D treatment chain from imaging to treatment delivery. Respiratory gated treatments are frequently used when the target volume is close to cardiac tissue, or for special treatments in which the tumor position depends on the respiratory cycle.
“It is a great pleasure to welcome the cancer center at Ryhov County Hospital to the fast-growing group of C-RAD customers,” says Tim Thurn, CEO of C-RAD. “Catalyst HD was developed specifically for the fast-growing segment of Stereotactic Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS), but at the same time Catalyst HD provides the proven advantages of the Catalyst system for treating breast cancer patients, as well as patients with other indications. In this way, the clinic can utilize the full range of advantages of surface tracking technology.”
About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. Employees currently number 43. C-RAD’s business originates from research and development at Karolinska Institutet in Solna, Sweden. Sales of the company’s first product, the C-RAD SentinelTM, started in 2007. Cooperation agreements have been signed with Elekta (Sweden), Varian (USA) and IBA (Belgium). C-RAD is represented by distributors specialized in radiation therapy on major markets. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are being integrated. C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit www.c-rad.com
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com
The above information is price-sensitive and must therefore be disclosed under the Securities Market Act (2007:528).
